Qingcheng Guo

Elimination of tumor by CD47/PD-L1 dual-targeting fusion protein that engages innate and adaptive immune responses

Boning Liu, Huaizu Guo, Jin Xu et al. · mAbs · 2017 · 91 citations · Full text

Adaptive Immune System, Immunology, Immunologic Mechanism +16

Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products

Qingqiao Tan, Qingcheng Guo, Fang Chen et al. · mAbs · 2012 · 59 citations · Full text

Immunology, Glycobiology, Immunotherapy +24

Acid-induced aggregation propensity of nivolumab is dependent on the Fc

Boning Liu, Huaizu Guo, Jin Xu et al. · mAbs · 2016 · 48 citations · Full text

Acid-induced Aggregation Propensity, Igg4 Antibody, Immunology +18

Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry

Lei Zhu, Qingcheng Guo, Huaizu Guo et al. · mAbs · 2014 · 46 citations · Full text

Development and Validation of LC–MS/MS Method for the Quantitation of Infliximab in Human Serum

Xiaoyun Peng, Boning Liu, Yantao Li et al. · Chromatographia · 2015 · 23 citations

Inflammation, Rheumatology, Autoimmune Disease +8